Evidence map›Paper›PMID 29941009›Full record

SynthesisOrphanet journal of rare diseases2018

Status of nutrients important in brain function in phenylketonuria: a systematic review and meta-analysis.

Gina A Montoya Parra, Rani H Singh, Aysun Cetinyurek-Yavuz, Mirjam Kuhn, Anita MacDonald

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Orphanet journal of rare diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 4 pooled it
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 4 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Gina A Montoya ParraDanone Nutricia Research, Nutricia Advanced Medical Nutrition, Utrecht, The Netherlands. gina.montoyaparra@danone.com.ORCID 0000-0003-2848-1339
Rani H SinghMetabolic Genetics and Nutrition Program, Emory University, Atlanta, GA, USA.
Aysun Cetinyurek-YavuzDanone Nutricia Research, Nutricia Advanced Medical Nutrition, Utrecht, The Netherlands.
Mirjam KuhnDanone Nutricia Research, Nutricia Advanced Medical Nutrition, Utrecht, The Netherlands.
Anita MacDonaldDepartment of Metabolic Diseases, Birmingham Children's Hospital, Birmingham, UK.
Nutricia Research (Netherlands) · NLBirmingham Children's Hospital · GBEmory University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite early and ongoing dietary management with a phe-restricted diet, suboptimal neuropsychological function has been observed in PKU. The restrictive nature of the PKU diet may expose patients to sub-optimal nutritional intake and deficiencies which may impact normal brain function. A systematic review of the published literature was carried out, where possible with meta-analysis, to compare the status of nutrients (Nutrients: DHA, EPA phospholipids, selenium, vitamins B

resultsOf 1534 publications identified, 65 studies met the entry criteria. Significantly lower levels of DHA, EPA and cholesterol were found for PKU patients compared to healthy controls. No significant differences in zinc, vitamins B

conclusionsThe current data show that PKU patients have lower availability of DHA, EPA and cholesterol. Compliance with the phe-restricted diet including the micronutrient fortified protein substitute (PS) is essential to ensure adequate micronutrient status. Given the complexity of the diet, patients' micronutrient and fatty acid status should be continuously monitored, with a particular focus on patients who are non-compliant or poorly compliant with their PS. Given their key role in brain function, assessment of the status of nutrients where limited data was found (e.g. choline, iodine) should be undertaken. Standardised reporting of studies in PKU would strengthen the output of meta-analysis and so better inform best practice for this rare condition.

Indexed as

BrainDocosahexaenoic AcidsFatty AcidsHumansMicronutrientsPhenylketonuriasPhospholipidsDocosahexaenoic AcidsFatty AcidsMicronutrientsPhospholipidsBrainCholesterol, cholineDocosahexaenoic acid (DHA)Eicosapentanoic acid (EPA)Fatty acidsMetabolismMicronutrients, phospholipids, complianceNutrientNutritional requirementPhenylketonuria (PKU)PlasmaVitamins

Identifiers

PMID29941009
PMCPMC6020171
OpenAlexW2809839116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.